Impact of target site mutations and plasmid associated resistance genes acquisition on resistance of Acinetobacter baumannii to fluoroquinolones
Among bacterial species implicated in hospital-acquired infections are the emerging Pan-Drug Resistant (PDR) and Extensively Drug-Resistant (XDR) Acinetobacter ( A .) baumannii strains as they are difficult to eradicate. From 1600 clinical specimens, only 100 A. baumannii isolates could be recovered...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2021-10, Vol.11 (1), p.20136-16, Article 20136 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Among bacterial species implicated in hospital-acquired infections are the emerging Pan-Drug Resistant (PDR) and Extensively Drug-Resistant (XDR)
Acinetobacter
(
A
.)
baumannii
strains as they are difficult to eradicate. From 1600 clinical specimens, only 100
A. baumannii
isolates could be recovered. A high prevalence of ≥ 78% resistant isolates was recorded for the recovered isolates against a total of 19 tested antimicrobial agents. These isolates could be divided into 12 profiles according to the number of antimicrobial agents to which they were resistant. The isolates were assorted as XDR (68; 68%), Multi-Drug Resistant (MDR: 30; 30%), and PDR (2; 2%). Genotypically, the isolates showed three major clusters with similarities ranging from 10.5 to 97.8% as revealed by ERIC-PCR technique. As a resistance mechanism to fluoroquinolones (FQs), target site mutation analyses in
gyrA
and
parC
genes amplified from twelve selected
A. baumannii
isolates and subjected to sequencing showed 12 profiles. The selected isolates included two CIP-susceptible ones, these showed the wild-type profile of being have no mutations. For the ten selected CIP-resistant isolates, 9 of them (9/10; 90%) had 1
gyrA
/1
parC
mutations (Ser 81 → Leu mutation for
gyrA
gene and Ser 84 → Leu mutation for
parC
gene). The remaining CIP-resistant isolate (1/10; 10%) had 0
gyrA
/1
parC
mutation (Ser 84 → Leu mutation for
parC
gene). Detection of plasmid-associated resistance genes revealed that the 86 ciprofloxacin-resistant isolates carry
qnrA
(66.27%; 57/86),
qnrS
(70.93%; 61/86),
aac (6')-Ib-cr
(52.32%; 45/86),
oqxA
(73.25%; 63/86) and
oqxB
(39.53%; 34/86), while
qepA
and
qnrB
were undetected in these isolates. Different isolates were selected from profiles 1, 2, and 3 and
qnrS, acc(6,)-ib-cr, oqxA,
and
oqxB
genes harbored by these isolates were amplified and sequenced. The BLAST results revealed that the
oqxA
and
oqxB
sequences were not identified previously in
A. baumannii
but they were identified in
Klebsiella aerogenes
strain NCTC9793 and
Klebsiella pneumoniae
, respectively. On the other hand, the sequence of
qnrS,
and
acc(6,)-ib-cr
showed homology to those of
A. baumannii
. MDR, XDR, and PDR
A. baumannii
isolates are becoming prevalent in certain hospitals. Chromosomal mutations in the sequences of GyrA and ParC encoding genes and acquisition of PAFQR encoding genes (up to five genes per isolate) are demonstrated to be resistance mechanisms exhibited by fluoroquinolones resistant
A. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-021-99230-y |